TikTok has done it again. One minute it's dance routines and pasta recipes, the next it's got everyone fixated on... earwax. Yes, really. The app that brought us skincare hacks and slugging is now ...

An ear infection can present as a dull, persistent ache, and is sometimes accompanied by pressure, discharge, itching, fever ...

Ustekinumab offers superior itch relief compared to guselkumab in severe psoriasis, despite guselkumab's better skin lesion improvement. The study involved 108 patients, with 90.4% of ustekinumab ...

It’s possible to get a tattoo if you have psoriasis. However, there are certain things to consider, such as the location and increased risk of possible complications. Share on Pinterest ...

Biosensor National Special Laboratory, Key Laboratory for Biomedical Engineering of Education Ministry, College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou 310027, ...

Psoriasis, a chronic autoimmune disease, is most commonly associated with symptoms that affect the skin. But it can also cause persistent fatigue, sometimes so severe that it reduces your quality ...

Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link between central fat and ...

Roflumilast foam is a steroid-free, once-daily treatment for plaque psoriasis, effective on the scalp and body. Clinical trials showed significant improvements in psoriasis clearance and itch ...

Each study participant was treated with a tVNS device for 60 minutes. The device works by resting on the ear and sending a pulse to the auricular (ear) branch of the vagus nerve. Overall ...

The foam formulation of the phosphodiesterase-4 (PDE4) inhibitor roflumilast has been approved by the US Food and Drug Administration (FDA) for treating plaque psoriasis of the scalp and body in ...

A new study has found the non-invasive application of in-ear electrical stimulation to the vagus nerve to be safe and effective in reducing osteoarthritis-related knee pain. It opens the door to ...

Accropeutics’ drug has hit the goals of a phase 2 psoriasis trial in China, prompting the biotech to pledge to “accelerate” the TYK2/JAK1 inhibitor’s clinical development. The study saw ...